-
281por Li, Li, Yu, Lu, He, Huan, Wei, Li, Xu, Zigang, Zhao, Libo, Sun, Yujuan, Zhang, Bin, Liu, Yuanxiang, He, Rui, Wang, Xiaoling, Ma, Lin“…BACKGROUND AND PURPOSE: This study was conducted to explore the plasma drug concentration of propranolol in Chinese Han patients with infantile haemangioma (IH) and the influencing factors, as well as the relationship among plasma drug concentrations of propranolol, β1-AR mutation and CYP2D6 188C>T, efficacy, and safety. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
282por Hu, Qian, Hu, Jiali, Chen, Cuiyu, Wang, Yang, Zhang, Yu, Wan, Jielin, Jing, Ouyang, Yi, Hanying, Wang, Shiyu, Huang, Weihua, Liu, Jie, Zhang, Wei, McLeod, Howard L., Xu, Ran, He, Yijing“…METHODS: The proliferation of bladder cancer cells treated with propranolol was detected by MTS assays. In vivo tumor xenograft experiments were used to observe the effect of propranolol on bladder cancer growth in mice. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
283por Fu, Ronghua, Zou, Yun, Wu, Zhiping, Jin, Pingliang, Cheng, Jun, Bai, Hanxiang, Huang, Mengyu, Huan, Xiangquan, Yuan, Hua“…Although the efficacy of propranolol in the treatment of infantile hemangioma (IH) has been well established, clinical data on the safety and tolerability of propranolol in neonates are still lacking. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
284por Younis, Mona K., Elakkad, Yara E., Fakhr Eldeen, Rasha R., Ali, Isra H., Khalil, Islam A.“…This study aims at preparing propranolol-loaded trehalosomes (a trehalose-coated liposome) to be used as an antiproliferative agent for treating skin cancer. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
285por Zito, R. A., Cassell, I., Cunningham, M., Gradman, A. H., Ross, A. M., Zaret, B. L.“…The high dose propranolol group had significantly higher plasma propranolol levels than the conventional dose group (788 +/- 134 SD vs. 43 +/- 7.2 ng/ml SD), and there was a direct linear relationship between propranolol dose and plasma drug levels (r = 0.85, P < 0.001). …”
Publicado 1980
Enlace del recurso
Enlace del recurso
Texto -
286por Filippi, Luca, Cavallaro, Giacomo, Fiorini, Patrizio, Daniotti, Marta, Benedetti, Valentina, Cristofori, Gloria, Araimo, Gabriella, Ramenghi, Luca, Torre, Agostino La, Fortunato, Pina, Pollazzi, Liliana, Marca, Giancarlo la, Malvagia, Sabrina, Bagnoli, Paola, Ristori, Chiara, Monte, Massimo Dal, Bilia, Anna Rita, Isacchi, Benedetta, Furlanetto, Sandra, Tinelli, Francesca, Cioni, Giovanni, Donzelli, Gianpaolo, Osnaghi, Silvia, Mosca, Fabio“…Propranolol will be administered until retinal vascularization will be completely developed, but not more than 90 days. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
287por Nagare, N., Damre, Anagha, Singh, K. S., Mallurwar, S. R., Iyer, Seethalakshmi, Naik, A., Chintamaneni, Meena“…Previously, permeability and site of intestinal absorption of propranolol have been reported using the Ussing chamber. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
288por Reboredo, Mercedes, Chang, Haisul C. Y., Barbero, Roberto, Rodríguez-Ortigosa, Carlos M., Pérez-Vizcaíno, Francisco, Morán, Asunción, García, Mónica, Banales, Jesús M., Carreño, Norberto, Alegre, Félix, Herrero, Ignacio, Quiroga, Jorge, Prieto, Jesús, Sangro, Bruno“…OBJECTIVE: Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure and its potential interaction with propranolol. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
289“…The matrix tablets containing the complexes were prepared and characterised with respect to propranolol release and were subsequently compared with those loading propranolol or a propranolol–magnesium aluminium silicate physical mixture. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
290
-
291“…In-vivo evaluation studies on propranolol hydrochloride mucoadhesive microspheres and propranolol hydrochloride powder were performed on normal healthy rabbits. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
292por Khajuria, Deepak Kumar, Disha, Choudhary, Razdan, Rema, Mahapatra, D. Roy, Vasireddi, Ramakrishna“…The anti-osteoporotic property of propranolol was comparable with zoledronic acid and alfacalcidol. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
293“…Beta-adrenergic blockers including propranolol can cause the retroperitoneal fibrosis disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
294“…In the act of remembering and re-storing traumatic memories, propranolol can act to dissociate the state of sympathetic arousal from their recollection. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
295por Ortiz, Vanesa, Giachero, Marcelo, Espejo, Pablo Javier, Molina, Víctor Alejandro, Martijena, Irene Delia“…METHODS: Here, we examined the effect of post-reactivation amnestic treatments such as Midazolam (MDZ, 3 mg/kg i.p) and Propranolol (PROP, 5 mg/kg i.p) on contextual fear memory reconsolidation in ethanol- withdrawn (ETOH) rats. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
296“…A meta-analysis of published data was conducted to investigate the effectiveness and safety of oral propranolol versus other treatments for infantile hemangiomas. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
297por Albiñana, Virginia, Villar Gómez de las Heras, Karina, Serrano-Heras, Gemma, Segura, Tomás, Perona-Moratalla, Ana Belén, Mota-Pérez, Mercedes, de Campos, José María, Botella, Luisa María“…HIF1-α and Hif-2α expression after propranolol treatment was analyzed by western blotting. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
298por Ösken, Altuğ, Yelgeç, Nizamettin Selçuk, Zehir, Regayip, Öz, Tuğba Kemaloğlu, Yaylacı, Selçuk, Akdemir, Ramazan, Gündüz, Hüseyin“…Chlorpheniramine and propranolol have the arrhythmogenic effects reported previously. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
299por Cardwell, Chris R., Pottegård, Anton, Vaes, Evelien, Garmo, Hans, Murray, Liam J., Brown, Chris, Vissers, Pauline A. J., O’Rorke, Michael, Visvanathan, Kala, Cronin-Fenton, Deirdre, De Schutter, Harlinde, Lambe, Mats, Powe, Des G., van Herk-Sukel, Myrthe P. P., Gavin, Anna, Friis, Søren, Sharp, Linda, Bennett, Kathleen“…BACKGROUND: Preclinical studies have demonstrated that propranolol inhibits several pathways involved in breast cancer progression and metastasis. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
300por Ji, Yi, Chen, Siyuan, Wang, Qi, Xiang, Bo, Xu, Zhicheng, Zhong, Lin, Yang, Kaiying, Lu, Guoyan, Qiu, Liqin“…Currently, propranolol is the most preferred systemic therapy for problematic infantile hemangiomas (IHs). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto